Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Girding For MDUFMA II: Premarket Review Unit Cost Study In Planning Phase

This article was originally published in The Gray Sheet

Executive Summary

FDA's unit cost analysis of premarket review resources may incite a long-term change to device user fee rates if certain application types prove more expensive to assess than previously believed
Advertisement

Related Content

PMA Review Costs Pooled In Unit-Cost Analysis; CDRH To Monitor Modules
PMA Review Costs Pooled In Unit-Cost Analysis; CDRH To Monitor Modules
CDRH Contracts Review Cost Auditor; Expedited, Modular PMAs On The Rise
CDRH Contracts Review Cost Auditor; Expedited, Modular PMAs On The Rise
Revised CDRH Modular Guidance Will Include Panel-Track Supplements
Oct. 20 Meeting Tentatively Scheduled For User Fees, Performance Goals
User Fees To Rise 16% As FDA Backs Historical Data Over Industry Estimates
Value Of Pre-IDE Meetings Debated; FDA To Explore Impact On PMAs
MDUFMA First Action: FDA Sets Review Milestones For Submissions
Small Manufacturer User Fee Discounts Draw 232 Applicants In Early FY 2004
Advertisement
UsernamePublicRestriction

Register

MT020617

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel